Hepcidin (Hepc) is a 25 amino acid cationic peptide with broad antibacterial and antifungal actions. A likely role for Hepc in iron metabolism was suggested by the observation that mice having disruption of the gene encoding the transcription factor USF2 failed to produce Hepc mRNA and developed spontaneous visceral iron overload. Lately, Hepc has been considered the "stores regulator," a putative factor that signals the iron content of the body to intestinal cells. In this work, we characterized the effect of Hepc produced by hepatoma cells on iron absorption by intestinal cells. To that end, human Hepc cDNA was cloned and overexpressed in HepG2 cells and conditioned media from Hepc-overexpressing cells was used to study the effects of Hepc on intestinal Caco-2 cells grown in bicameral inserts. The results indicate that Hepc released by HepG2 inhibited apical iron uptake by Caco-2 cells, probably by inhibiting the expression of the apical transporter DMT1. These results support a model in which Hepc released by the liver negatively regulates the expression of transporter DMT1 in the enterocyte.
INTRODUCTION
Hepcidin (Hepc) is a 25 amino acid cationic peptide with broad antibacterial and antifungal actions. It is predominantly expressed in the liver and has been detected in blood and urine (Ganz et al., 2004) . The human Hepc gene contains three exons that encode a 94-aminoacid pro-hepcidin with a characteristic furin cleavage site immediately N-terminal to the 25-amino acid mature peptide. In addition to the 25-amino acid form, the urine also contains minor 20-and 22-amino-acid forms truncated at the Nterminus (Kulaksiz et al., 2004) . Analysis of the sequence of Hepc revealed that the protein contains eight cysteines. Mass spectroscopy and chemical analysis revealed that all of the cysteines are bridged in the sequence, making Hepc a highly constrained peptide (Park et al., 2001) .
A likely role for Hepc in iron metabolism was suggested by the observation that mice having disruption of the gene encoding the transcription factor USF2 failed to produce Hepc mRNA and developed spontaneous visceral iron overload (Nicolas et al., 2001) .
Lately, Hepc has been considered the "stores regulator," a putative factor that signals the iron content of the body to intestinal cells. Hepc expression and secretion by the liver correlate directly with hepatic iron levels. Once secreted, Hepc produces inhibition of intestinal iron absorption by the enterocyte. Thus, Hepc mediates a regulatory cycle of iron absorption between the liver and the intestine (reviewed in Andrews, 2004) .
In this work, we characterized the effect of Hepc produced by hepatoma cells on iron absorption by intestinal cells. 55 Fe uptake from the apical media was performed (Fig.  1) . We found that Hepc decreased apical iron uptake, whereas the transfer step to the basolateral media was not affected. The inhibitory effect on apical 55 Fe uptake for Hepc was obliterated when the media was first treated with Sepharose-bound antiHepc antibody. Determination of Hepc effect on DMT1 and Ireg1 expression in Caco-2 cells. RNA from Caco-2 cells treated for 48 hours with Hepc-conditioned medium was analyzed for DMT1 and Ireg1 mRNA expression by semi-quantitative RT-PCR. A two-to three-fold decrease in DMT1 mRNA expression was observed in Hepctreated cells when compared to cells treated with control media. In contrast, no changes in Ireg1 mRNA expression were readily apparent (Mena et al., manuscript in preparation). These results agree with the 55 Fe transport experiments, where only apical iron uptake was affected.
In summary, the results indicate that Hepc released by HepG2 inhibited apical iron uptake by Caco-2 cells, probably by inhibiting the expression of the apical transporter DMT1.
These results support a model in which Hepc released by the liver negatively regulates the expression of transporter DMT1 in the enterocyte.
